Accumulated proceeds of $3 million including the initial closing held in March 2025 ZÜRICH, June 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on developing therapies for central nervous...
Hence then, the article about nls pharmaceutics and kadimastem announce pricing and closing of 1 million equity financing was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing )
Also on site :
- Former UFC Star Shot 3 Times in Deadly Congo Ambush While on Mission for Blackwater Founder’s Security Firm
- In 1970, Oregon highway crews packed a dead 45-foot sperm whale with a half-ton of dynamite; the blast rained blubber on spectators and crushed a new car a quarter-mile away
- Léa Seydoux & Marie Kreutzer On The “Earthquake” At The Heart Of ‘Gentle Monster’ — Contenders London